Results also demonstrate the benefits for patients of Abbott's TriClip™ for tricuspid regurgitation, Amulet™ for atrial fibrillation and Portico™ for aortic stenosis
September 17, 2022
Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technologies
September 17, 2022 — Abbott today announced data from five late-breaking presentations showing the benefits of its…
Read More
Pathological Findings Confirm Importance of Early Detection and Treatment of Thrombus on Valve Leaflets
September 17, 2022
First-ever Comparison of MicroCT and Histology in Self-expanding Transcatheter Aortic Valve Replacement Patients with Hypo-attenuated Leaflet Thickening
September 17, 2022 — Medtronic today announced findings from its Pathological Study of Hypo-Attenuated Leaflet…
Read More
The Impella CP with SmartAssist heart pump is a minimally invasive, temporary heart pump that uses real-time intelligence associated with improved survival and heart recovery. (Graphic: Business Wire)
September 17, 2022
Unloading with Impella for 30 Minutes Before PCI Associated with Reduced Infarct Size in STEMI Patients
September 17, 2022 — Results of a new per-protocol analysis of the ST-segment Elevation Myocardial Infarction Door-To-…
Read More
Results from largest randomized TAVR trial to date presented at TCT 2022
September 17, 2022
Late-Breaking Data from PROTECTED TAVR Trial Demonstrate Reduced Risk of Disabling Stroke, Low Complication Rate with SENTINEL Cerebral Protection System
September 17, 2022 —  Boston Scientific Corporation has announced results from the PROTECTED TAVR clinical trial…
Read More
Edwards Lifesciences Corporation, today announced the company's PASCAL Precision transcatheter valve repair system for transcatheter edge-to-edge repair (TEER) has received FDA approval for the treatment of patients with degenerative mitral regurgitation (DMR).
September 16, 2022
Edwards Pascal Precision Transcatheter Valve Repair System Receives FDA Approval for Degenerative Mitral Regurgitation
September 16, 2022 — Edwards Lifesciences Corporation, today announced the company's PASCAL Precision transcatheter …
Read More
Results from Largest Ever Real-World Evaluation of the MANTA Device Demonstrated Safety and Effectiveness with Low Complication Rates and a Short Learning Curve
September 16, 2022
Co-Author of the Karolinska 1000 Consecutive MANTA Vascular Closure Device Study to Present Learnings at the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Conference
September 16, 2022 — Teleflex Incorporated, a leading global provider of medical technologies, announced that Dr.…
Read More
The CathWorks FFRangio System to Be Featured in Multiple Live Cases and Clinical Presentations at TCT 2022
September 16, 2022
CathWorks Announces Key Events for TCT 2022
September 16, 2022 — CathWorks announced today the schedule of key events for the company during Cardiovascular…
Read More
RECOVER IV is an on-label, two arm RCT that is designed to provide the clinical evidence needed to achieve a Class I guideline recommendation for Impella use in AMI cardiogenic shock.
September 16, 2022
FDA Approves RECOVER IV Randomized Controlled Trial with Exception from Informed Consent (EFIC)
September 16, 2022 — Abiomed announced two approvals from the U.S. Food and Drug Administration (FDA) related to…
Read More
Study suggests prescribing Philips MCOT (Mobile Cardiac Outpatient Telemetry) solution may support improved patient outcomes and cost savings by monitoring for arrhythmic disturbances and encouraging timely intervention
September 15, 2022
New Study Validates Ambulatory Monitoring as a Critical Component of Cardiac Care
September 15, 2022 — Today, aortic stenosis (AS) is one of the most common and serious valve disease problems [1]. It…
Read More
Dr. Valentin Fuster to be honored with the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Career Achievement Award. Image courtesy of Mount Sinai Health System
September 15, 2022
Valentin Fuster, M.D., Ph.D., Receives Prestigious Award from Cardiovascular Research Foundation
September 15, 2022 — The Cardiovascular Research Foundation (CRF) will honor Valentin Fuster, MD, PhD, Director of…
Read More
Global consensus data recommends the use of intravascular ultrasound (IVUS) in many peripheral vascular disease (PVD) procedures
September 15, 2022
Philips Showcases Clinical Data and Solutions Designed to Deliver Better Cardiac Care with Greater Efficiency at TCT 2022
September 15, 2022 — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase its…
Read More
Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital health company designed the app to support researchers and advance the adoption of digital health technology in cardiac practice.
September 15, 2022
European digital health company launches app to support cardiac health
September 15, 2022 - Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital…
Read More
Cardiac Implants LLC has announced the successful initial deployment of its Annuloplasty ring with implementation of a therapeutic adjustment procedure using its innovative Tri-Ring percutaneous annuloplasty device.
September 15, 2022
Cardiac Implants Announces Successful Therapeutic Adjustment Procedure Using Tri-Ring Percutaneous Annuloplasty Device
September 15, 2022 — Cardiac Implants LLC has announced the successful initial deployment of its Annuloplasty ring with…
Read More
Details on late-breaking clinical trials to be presented during The VEINS (Venous Endovascular INterventional Strategies) and VIVA (Vascular InterVentional Advances) Annual Conference, Oct. 30-Nov. 3, 2022, have been announced.
September 14, 2022
Late-breaking Clinical Trial presentations announced for The VEINS and VIVA Conference
September 14, 2022 — Details on late-breaking clinical trials to be presented during The VEINS (Venous Endovascular …
Read More
A budget impact analysis published in the Canadian Journal of Cardiology compared the use of surgical (SAVR) versus catheter-based transcatheter aortic valve replacement (TAVR)
September 14, 2022
TAVR is an Affordable and Effective Strategy for Treating Aortic Stenosis Patients
September 14, 2022 — Minimally invasive, catheter-based transcatheter aortic valve replacement (TAVR) has…
Read More
Phase III clinical trial of [18F]flurpiridaz PET diagnostic radiopharmaceutical meets co-primary endpoints for detecting Coronary Artery Disease (CAD)
September 14, 2022
GE Healthcare and Lantheus Phase III Clinical Trial Finds [18F]flurpiridaz PET Radiotracer Could Improve Detection of Coronary Artery Disease
September 14, 2022 — GE Healthcare and Lantheus Holdings Inc have announced that the recent Phase III clinical trial of…
Read More
Findings reveal AFib patients are fearful of complications from the condition, but not all are treating their AFib quicky after diagnosis
September 14, 2022
Biosense Webster AFib Survey Findings Reveal Surprising Patient Behaviors and At-Risk Population Awareness Gaps
September 14, 2022 — In recognition of Atrial Fibrillation (AFib) Awareness Month, Biosense Webster, Inc., part of…
Read More
Anthos Therapeutics has announced that Abelacimab has received FDA Fast Track Designation for the prevention of stroke and systemic embolism in patients with atrial fibrillation.
September 13, 2022
Anthos Therapeutics Announces Abelacimab Received FDA Fast Track Designation for the Prevention of Stroke and Systemic Embolism in Patients with AFib
September 13, 2022 — Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for…
Read More
The ĹŚNĹŚ endovascular retrieval system was recently used to remove a malpositioned leadless pacemaker (LPM) that embolized to the right pulmonary artery in a 52- year-old patient, ĹŚNĹŚCOR LLC announced.
September 13, 2022
First-In-Human Use of the ĹŚNĹŚ Retrieval System for Percutaneous Removal of an Embolized Leadless Pacemaker from the Right Pulmonary Artery
September 13, 2022 — The ŌNŌ endovascular retrieval system was recently used to remove a malpositioned leadless…
Read More
TherOx Console
September 13, 2022
First Patient Enrolled in AMIHOT III Trial Investigating ZOLL’s Supersaturated Oxygen Therapy in Heart Attack Patients
September 13, 2022 — ZOLL Medical Corporation, an Asahi Kasei company that manufactures medical devices and related…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now